NCT05202353View on ClinicalTrials.gov

A Study in People With Obesity to Test the Effects of BI 456906 Compared With Semaglutide on Glucagon Receptor Activity in the Liver

PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

October 7, 2026

Study Completion Date

November 2, 2026

Conditions
Obesity
Interventions
DRUG

BI 456906

BI 456906

DRUG

Semaglutide

Semaglutide

Trial Locations (1)

1105 AZ

RECRUITING

Amsterdam UMC, location VUMC, Amsterdam

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY